Cargando…
Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition
OBJECTIVE: The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). METHODS: 120 Wistar rats were randomly divided into six...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335662/ https://www.ncbi.nlm.nih.gov/pubmed/30719057 http://dx.doi.org/10.1155/2019/2710509 |
_version_ | 1783387930666991616 |
---|---|
author | Meng, Lihong Zhang, Xiaomei Wang, Hong Dong, Huan Gu, Xiaofeng Yu, Xiaolin Liu, Yushan |
author_facet | Meng, Lihong Zhang, Xiaomei Wang, Hong Dong, Huan Gu, Xiaofeng Yu, Xiaolin Liu, Yushan |
author_sort | Meng, Lihong |
collection | PubMed |
description | OBJECTIVE: The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). METHODS: 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-β1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-β1, TβRI, TβRII, Smad3, Smad7, α-SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. RESULTS: TGF-β1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-β1, CTGF, hydroxyproline contents, and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. CONCLUSION: These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-β1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats. |
format | Online Article Text |
id | pubmed-6335662 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-63356622019-02-04 Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition Meng, Lihong Zhang, Xiaomei Wang, Hong Dong, Huan Gu, Xiaofeng Yu, Xiaolin Liu, Yushan Evid Based Complement Alternat Med Research Article OBJECTIVE: The aim of the current study was to investigate the protective effect of Yangyin Yiqi Mixture (YYYQ) on Bleomycin-induced pulmonary fibrosis in rats based on TGF-β1/Smad signal pathway and epithelial to mesenchymal transition (EMT). METHODS: 120 Wistar rats were randomly divided into six groups: control group, BLM group, BLM + Pred group, BLM+YYYQ-L group, BLM+YYYQ-M group, and BLM+YYYQ-H group. Rats were given an intratracheal instillation of 3 mg/kg BLM to establish the pulmonary fibrosis model and followed by different dosages of YYYQ (11, 22, 44g/kg, via intragastric gavage) or prednisone soluble (4.2mg/kg, via intragastric gavage) or water. After 14 days and 28 days, tissue sections were stained with hematoxylin-eosin and Masson's trichrome to observe histopathological changes. Protein levels of TGF-β1, CTGF, Interleukin 18, and hydroxyproline were detected by ELISA method, and mRNA expressions of TGF-β1, TβRI, TβRII, Smad3, Smad7, α-SMA, E-cadherin, laminin, and collagen I were detected by RT-PCR. RESULTS: TGF-β1, CTGF, Interleukin 18, and hydroxyproline levels and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I were significantly increased (p <0.01), while Smad7 and E-cadherin levels were significantly decreased in BLM group (p <0.01). YYYQ-M and YYYQ-H group had downregulated the TGF-β1, CTGF, hydroxyproline contents, and mRNA expression of TGF-β1, TβRI, TβRII, Smad3, α-SMA, laminin, and collagen I and upregulated mRNA levels of Smad7 and E-cadherin significantly (p <0.01 or p <0.05). The result from the present study, which was also supported by histological evidence, suggested that YYYQ-M group and YYYQ-H group exhibited better treatment effect on Bleomycin-induced pulmonary fibrotic rats when compared to that of BLM + Pred group (p <0.01). Meanwhile, the effect of YYYQ, in three different dosages, on the level of interleukin 18 was not significant. CONCLUSION: These results showed that YYYQ has the potential of ameliorating the progression of pulmonary fibrosis, and the mechanism may be related to suppressing TGF-β1/Smad signal pathway and EMT in BLM-induced pulmonary fibrosis of rats. Hindawi 2019-01-03 /pmc/articles/PMC6335662/ /pubmed/30719057 http://dx.doi.org/10.1155/2019/2710509 Text en Copyright © 2019 Lihong Meng et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Meng, Lihong Zhang, Xiaomei Wang, Hong Dong, Huan Gu, Xiaofeng Yu, Xiaolin Liu, Yushan Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition |
title | Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition |
title_full | Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition |
title_fullStr | Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition |
title_full_unstemmed | Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition |
title_short | Yangyin Yiqi Mixture Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats through Inhibiting TGF-β1/Smad Pathway and Epithelial to Mesenchymal Transition |
title_sort | yangyin yiqi mixture ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting tgf-β1/smad pathway and epithelial to mesenchymal transition |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335662/ https://www.ncbi.nlm.nih.gov/pubmed/30719057 http://dx.doi.org/10.1155/2019/2710509 |
work_keys_str_mv | AT menglihong yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition AT zhangxiaomei yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition AT wanghong yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition AT donghuan yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition AT guxiaofeng yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition AT yuxiaolin yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition AT liuyushan yangyinyiqimixtureamelioratesbleomycininducedpulmonaryfibrosisinratsthroughinhibitingtgfb1smadpathwayandepithelialtomesenchymaltransition |